Form 4 for NVAX NOVAVAX INC
Accepted 2026-03-12 00:00:00 ET · period of report 2026-03-10 · accession 0001104659-26-027143 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-12 | 2026-03-10 | NVAX | Shiver John W. | Dir | M - OptEx | $0.00 | +7,947 | 7,947 | New | $0 |
| D | 2026-03-12 | 2026-03-10 | NVAX | Shiver John W. | Dir | M - OptEx | $0.00 | -7,947 | 15.9K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-10 | M | A | 7,947 | $0.00 | 7,947 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2026-03-10 | M | D | 7,947 | $0.00 | 15,893 | D | $0.00 · — to 2035-03-10 | 7,947 Common Stock | (F1) The RSUs subject to this grant under the Restated 2015 Stock Incentive Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of March 10, 2025, in each case subject to continued service on the Company's Board of Directors through such vesting date |